Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-17

Clinical Trial Update: Safety of Cultured Allogeneic Adult Umbilical Cord Stem Cells Exosomes for Trigeminal Neuralgia [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating safety of cultured allogeneic adult umbilical cord stem cell-derived exosomes for trigeminal neuralgia; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Umbilical cord stem cell-derived exosomes (exosome preparation from cultured allogeneic human umbilical cord mesenchymal stem cells)

Snippet

Sponsor: The Foundation for Orthopaedics and Regenerative Medicine | Conditions: Peripheral Neuropathy, Trigeminal Neuralgia | Phase 1 | Status: RECRUITING